tiprankstipranks
Trending News
More News >
Hong Kong Pharma Digital Technology Holdings Ltd. (HKPD)
NASDAQ:HKPD
US Market
Advertisement

Hong Kong Pharma Digital Technology Holdings Ltd. (HKPD) Stock Statistics & Valuation Metrics

Compare
23 Followers

Total Valuation

Hong Kong Pharma Digital Technology Holdings Ltd. has a market cap or net worth of ―. The enterprise value is ―.
Market Cap
Enterprise Value

Share Statistics

Hong Kong Pharma Digital Technology Holdings Ltd. has 11,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,000,000
Owned by Insiders
Owned by Institutions0.32%

Financial Efficiency

Hong Kong Pharma Digital Technology Holdings Ltd.’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -1.34%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-1.34%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee1.07M
Profits Per Employee-1.42K
Employee Count19
Asset Turnover2.16
Inventory Turnover31.96

Valuation Ratios

The current PE Ratio of Hong Kong Pharma Digital Technology Holdings Ltd. is ―. Hong Kong Pharma Digital Technology Holdings Ltd.’s PEG ratio is 3.55.
PE Ratio
PS Ratio0.48
PB Ratio1.95
Price to Fair Value1.95
Price to FCF23.52
Price to Operating Cash Flow24.37
PEG Ratio3.55

Income Statement

In the last 12 months, Hong Kong Pharma Digital Technology Holdings Ltd. had revenue of 20.31M and earned -27.06K in profits. Earnings per share was 0.00.
Revenue20.31M
Gross Profit2.42M
Operating Income132.04K
Pretax Income36.11K
Net Income-27.06K
EBITDA1.21M
Earnings Per Share (EPS)0.00

Cash Flow

In the last 12 months, operating cash flow was 569.21K and capital expenditures -69.92K, giving a free cash flow of 499.30K billion.
Operating Cash Flow569.21K
Free Cash Flow499.30K
Free Cash Flow per Share0.05

Dividends & Yields

Hong Kong Pharma Digital Technology Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.09
52-Week Price Change-56.13%
50-Day Moving Average1.29
200-Day Moving Average
Relative Strength Index (RSI)42.79
Average Volume (3m)272.13K

Important Dates

Hong Kong Pharma Digital Technology Holdings Ltd. upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

Hong Kong Pharma Digital Technology Holdings Ltd. as a current ratio of 2.99, with Debt / Equity ratio of 47.59%
Current Ratio2.99
Quick Ratio2.80
Debt to Market Cap0.19
Net Debt to EBITDA1.35
Interest Coverage Ratio1.35

Taxes

In the past 12 months, Hong Kong Pharma Digital Technology Holdings Ltd. has paid 63.17K in taxes.
Income Tax63.17K
Effective Tax Rate1.75

Enterprise Valuation

Hong Kong Pharma Digital Technology Holdings Ltd. EV to EBITDA ratio is 9.42, with an EV/FCF ratio of 27.45.
EV to Sales0.56
EV to EBITDA9.42
EV to Free Cash Flow27.45
EV to Operating Cash Flow19.97

Balance Sheet

Hong Kong Pharma Digital Technology Holdings Ltd. has $3.01M in cash and marketable securities with $2.37M in debt, giving a net cash position of $630.68K billion.
Cash & Marketable Securities$3.01M
Total Debt$2.37M
Net Cash$630.68K
Net Cash Per Share$0.06
Tangible Book Value Per Share$0.54

Margins

Gross margin is 11.89%, with operating margin of 0.65%, and net profit margin of -0.13%.
Gross Margin11.89%
Operating Margin0.65%
Pretax Margin0.18%
Net Profit Margin-0.13%
EBITDA Margin5.94%
EBIT Margin0.66%

Analyst Forecast

The average price target for Hong Kong Pharma Digital Technology Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis